ÂÜÀòÂÒÂ×

Yongbo Hu is an accomplished professional in the biotechnology and pharmaceutical industries, currently serving as Director II at WuXi Biologics since April 2021, focusing on business development for WuXi XDC. Prior roles include BD Director II at STA Pharmaceutical, BD Director at Jiuzhou Pharma, and Senior Director at AstaTech BioPharmaceutical Corp. Yongbo's expertise in crystallization processes and API development was further demonstrated as CEO and CoFounder of Charm PharmaTech, where innovative crystal forms of sofosbuvir were developed. Earlier career milestones include significant contributions at Eisai, progressing from Researcher to Senior Scientist, and academic roles at Boston University. Yongbo holds an MBA from the Questrom School of Business and advanced degrees in Chemistry and Fine Chemical Engineering from Boston University and East China University of Science and Technology.